FDA peptide reviews explained: what the hype gets wrong

What did @pushmed actually say?

The creator claims that "as of April 15th, 2026, the FDA has released some news that they are going to remove the restrictions surrounding peptides" and that this means patients will soon have proper access to compounds like BPC-157 and TB-500. They frame it as "an exciting day today for anti-aging." That is a significant regulatory claim, and it deserves serious scrutiny before anyone cancels their current treatment plan or starts shopping for peptides.

To be clear: the claim is not that peptides are now legal or approved. The creator says FDA is moving toward reviewing a pathway. That is a narrower claim, but still one that needs verification before a telehealth platform uses it to generate excitement among patients.

Does the science back this up?

The science on these specific peptides is genuinely promising but far from settled. That matters here because regulatory status and scientific evidence are two different things, and the video conflates the excitement around both.

BPC-157 (Body Protection Compound-157) has shown regenerative effects in rodent models, with studies like Sikiric et al. (2018, Current Pharmaceutical Design) documenting accelerated tendon and gut healing in animal subjects. TB-500, a synthetic derivative of Thymosin Beta-4, has similarly shown tissue repair activity in preclinical work (Goldstein et al., 2012, Annals of the New York Academy of Sciences). However, neither compound has completed Phase III human clinical trials. The FDA does not approve drugs based on animal data alone. Any pathway toward legal dispensing would require robust human safety and efficacy data that does not yet publicly exist for these compounds.

So the science is interesting. The clinical evidence in humans is thin. Those are two facts that need to live in the same sentence.

What did they get wrong (or right)?

Here is where things get complicated. As of the knowledge available through mid-2025, the FDA had not issued any formal announcement removing restrictions on BPC-157 or TB-500. In fact, the FDA's 2023 guidance placed several bulk peptides, including BPC-157, on a list of substances that cannot be compounded under Section 503A and 503B of the Federal Food, Drug, and Cosmetic Act. That was a restriction, not a loosening.

The creator references an April 15th, 2026 date. FormBlends cannot independently verify a specific FDA action on that date. What we can say is that any claim of FDA "removing restrictions" on these compounds would represent a dramatic reversal of recent policy, and would warrant an official FDA press release, Federal Register notice, or formal guidance document, not a TikTok announcement from a telehealth company.

The creator does get credit for not claiming BPC-157 treats or cures any disease, and for framing this as a developing situation requiring further guidance. That is honest. The excitement around an unverified regulatory claim is the problem.

What should you actually know?

The FDA's relationship with compounded peptides has been restrictive and getting more so in recent years, not less. In 2023 and 2024, the agency moved to restrict bulk compounding of several peptides that had become popular in wellness clinics, citing insufficient clinical data to establish safety profiles for compounded versions. BPC-157 specifically was flagged as a substance that presents "demonstrable difficulties" for compounding and lacks adequate human safety data.

If a regulatory shift did occur in April 2026, patients should look for official documentation: a Federal Register entry, an FDA guidance update, or a formal policy statement. A telehealth company's TikTok video is not that documentation. Companies that profit from peptide sales have a financial interest in framing regulatory news as favorable, even when the details are uncertain.

If you are currently using or considering peptide therapy, talk to a licensed provider who can walk you through what is actually legal and compoundable in your state, and what the actual human evidence says, not just the animal models.